The post Bitcoin BETA ETF Launches on Warsaw Stock Exchange appeared on BitcoinEthereumNews.com. Poland’s Bitcoin BETA ETF launches on GPW, offering regulated Bitcoin exposure via futures contracts without owning the cryptocurrency directly. Poland has taken a big step into the world of digital finance. The Warsaw Stock Exchange (GPW) has officially launched the Bitcoin BETA ETF. It is an investment product that is new and can enable individuals to have exposure to Bitcoin, but without owning the coin itself. This action is regarded as a significant advancement to the Polish financial sphere and its expanding ETF capital. Bitcoin BETA ETF Targets Investors Avoiding Crypto Exchanges This fund does not possess actual Bitcoin, unlike spot Bitcoin ETFs. It instead trades futures contracts at the Chicago Mercantile Exchange (CME) to expose itself to the cryptocurrency. AgioFunds TFI SA is a reputable fund management company in Poland that manages the ETF. This has led to a regulated and transparent means of investing in the Bitcoin by Polish investors via the conventional stock market. It will be particularly handy to individuals interested in crypto but not willing to use digital wallets or exchanges. Related Reading: Grayscale Launches First U.S. Multi-Asset Crypto ETF on NYSE Arca | Live Bitcoin News Besides, the introduction of the Bitcoin BETA ETF is timed with the need to note that the trading in ETFs is currently developing at a high rate in Poland. To date, this year ETF turnover on GPW has reached PLN 1.9 billion making 94.2 percent increase in comparison with the turnover of the previous year. It is evident that increasing numbers of investors are resorting to ETFs due to their simplicity, cheapness and simplicity in trading. Moreover, the GPW currently has 16 ETFs. They include funds which follow the popular Polish indexes such as WIG20, mWIG40 and sWIG80. Major global indexes have also ETFs e.g. S&P 500, Nasdaq-100… The post Bitcoin BETA ETF Launches on Warsaw Stock Exchange appeared on BitcoinEthereumNews.com. Poland’s Bitcoin BETA ETF launches on GPW, offering regulated Bitcoin exposure via futures contracts without owning the cryptocurrency directly. Poland has taken a big step into the world of digital finance. The Warsaw Stock Exchange (GPW) has officially launched the Bitcoin BETA ETF. It is an investment product that is new and can enable individuals to have exposure to Bitcoin, but without owning the coin itself. This action is regarded as a significant advancement to the Polish financial sphere and its expanding ETF capital. Bitcoin BETA ETF Targets Investors Avoiding Crypto Exchanges This fund does not possess actual Bitcoin, unlike spot Bitcoin ETFs. It instead trades futures contracts at the Chicago Mercantile Exchange (CME) to expose itself to the cryptocurrency. AgioFunds TFI SA is a reputable fund management company in Poland that manages the ETF. This has led to a regulated and transparent means of investing in the Bitcoin by Polish investors via the conventional stock market. It will be particularly handy to individuals interested in crypto but not willing to use digital wallets or exchanges. Related Reading: Grayscale Launches First U.S. Multi-Asset Crypto ETF on NYSE Arca | Live Bitcoin News Besides, the introduction of the Bitcoin BETA ETF is timed with the need to note that the trading in ETFs is currently developing at a high rate in Poland. To date, this year ETF turnover on GPW has reached PLN 1.9 billion making 94.2 percent increase in comparison with the turnover of the previous year. It is evident that increasing numbers of investors are resorting to ETFs due to their simplicity, cheapness and simplicity in trading. Moreover, the GPW currently has 16 ETFs. They include funds which follow the popular Polish indexes such as WIG20, mWIG40 and sWIG80. Major global indexes have also ETFs e.g. S&P 500, Nasdaq-100…

Bitcoin BETA ETF Launches on Warsaw Stock Exchange

Poland’s Bitcoin BETA ETF launches on GPW, offering regulated Bitcoin exposure via futures contracts without owning the cryptocurrency directly.

Poland has taken a big step into the world of digital finance. The Warsaw Stock Exchange (GPW) has officially launched the Bitcoin BETA ETF. It is an investment product that is new and can enable individuals to have exposure to Bitcoin, but without owning the coin itself. This action is regarded as a significant advancement to the Polish financial sphere and its expanding ETF capital.

Bitcoin BETA ETF Targets Investors Avoiding Crypto Exchanges

This fund does not possess actual Bitcoin, unlike spot Bitcoin ETFs. It instead trades futures contracts at the Chicago Mercantile Exchange (CME) to expose itself to the cryptocurrency. AgioFunds TFI SA is a reputable fund management company in Poland that manages the ETF.

This has led to a regulated and transparent means of investing in the Bitcoin by Polish investors via the conventional stock market. It will be particularly handy to individuals interested in crypto but not willing to use digital wallets or exchanges.

Related Reading: Grayscale Launches First U.S. Multi-Asset Crypto ETF on NYSE Arca | Live Bitcoin News

Besides, the introduction of the Bitcoin BETA ETF is timed with the need to note that the trading in ETFs is currently developing at a high rate in Poland. To date, this year ETF turnover on GPW has reached PLN 1.9 billion making 94.2 percent increase in comparison with the turnover of the previous year. It is evident that increasing numbers of investors are resorting to ETFs due to their simplicity, cheapness and simplicity in trading.

Moreover, the GPW currently has 16 ETFs. They include funds which follow the popular Polish indexes such as WIG20, mWIG40 and sWIG80. Major global indexes have also ETFs e.g. S&P 500, Nasdaq-100 and DAX. Bitcoin BETA ETF is even more of an expansion of its product as the exchange has moved to include digital assets.

Bitcoin BETA ETF Offers Transparent Path to Digital Assets

Lazer (2008) argues that the new ETF is based on an apparent market demand according to Kazimierz Szpak, the CEO of BETA TFI SA. He said that investors are now seeking new investment types, and the ETF provides an easy and transparent means of getting access to Bitcoin.

Moreover, the introduction of Bitcoin ETFs in Poland makes it one of the global financial hubs, such as the U.S. and Germany, which already have accessible Bitcoin ETFs. It points to the increased significance of GPW in the global ETF market, particularly the increase in attention to crypto-based products globally.

Also, this ETF has the potential to draw in more institutional and retail investors who were initially apprehensive about the outright purchase of Bitcoin. Its structure is futures, which provides certain risk control, but at the same time, it rides the price movement of the largest cryptocurrency in the world.

To sum it up, the launch of the Bitcoin BETA ETF is a breakthrough in the financial market of Poland. It provides a licensed, well-known, and convenient means of investing in Bitcoin, as well as it assists in the extensive expansion of ETFs in the Warsaw Stock Exchange. Poland has developed into a futuristic participant in the changing landscape of crypto finance as more investors look to be exposed to digital assets.

Source: https://www.livebitcoinnews.com/bitcoin-beta-etf-launches-on-warsaw-stock-exchange/

Market Opportunity
Gravity Logo
Gravity Price(G)
$0.004503
$0.004503$0.004503
+4.69%
USD
Gravity (G) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26